HemaSphere
(Mar 2024)
Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma
- George Mellgard,
- Molly Gilligan,
- Edward R. Scheffer Cliff,
- Divaya Bhutani,
- Ghulam R. Mohyuddin,
- Andrew Eisenberger,
- Suzanne Lentzsch,
- Rajshekhar Chakraborty
Affiliations
- George Mellgard
- Department of Medicine Columbia University Irving Medical Center New York New York USA
- Molly Gilligan
- Department of Medicine Columbia University Irving Medical Center New York New York USA
- Edward R. Scheffer Cliff
- Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA
- Divaya Bhutani
- Columbia University Herbert Irving Comprehensive Cancer Center New York New York USA
- Ghulam R. Mohyuddin
- University of Utah Salt Lake City Utah USA
- Andrew Eisenberger
- Columbia University Herbert Irving Comprehensive Cancer Center New York New York USA
- Suzanne Lentzsch
- Columbia University Herbert Irving Comprehensive Cancer Center New York New York USA
- Rajshekhar Chakraborty
- Columbia University Herbert Irving Comprehensive Cancer Center New York New York USA
- DOI
-
https://doi.org/10.1002/hem3.61
- Journal volume & issue
-
Vol. 8,
no. 3
pp.
n/a
– n/a
WeChat QR code